Moderna stock tumbled 10.5 percent in pre-market trading early Wednesday morning, after the Food and Drug Administration rejected the drug giant’s application for an experimental flu vaccine using mRNA technology. Currently, only COVID-19 vaccines use mRNA (messenger Ribonucleic Acid) technology. Health and Human Services director Robert F. Kennedy Jr. has…
News24 | Iran vows defiance against US military threats on revolution anniversary
...
Read moreDetails
